Basit öğe kaydını göster

dc.contributor.authorCAYCI, Yeliz Tanriverdi
dc.contributor.authorGunaydin, Murat
dc.contributor.authorYilmaz, Hava
dc.contributor.authorKaradag, Adil
dc.contributor.authorEsen, Saban
dc.contributor.authorYanik, Kerametrin
dc.date.accessioned2021-03-04T15:00:46Z
dc.date.available2021-03-04T15:00:46Z
dc.date.issued2014
dc.identifier.citationYanik K., Yilmaz H., CAYCI Y. T. , Karadag A., Esen S., Gunaydin M., "GLYCOPEPTIDES AND LINEZOLID MIC CHANGES IN STAPHYLOCOCCUS AUREUS AND COAGULASE NEGATIVE STAPHYLOCOCCI ISOLATES FROM 2008-2011", ACTA MEDICA MEDITERRANEA, cilt.30, sa.5, ss.993-996, 2014
dc.identifier.issn0393-6384
dc.identifier.othervv_1032021
dc.identifier.otherav_848b08d9-5498-4d0c-9ced-655965a5bdd2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/90151
dc.description.abstractAims: Glycopeptides and linezolid are the antimicrobial agents used for the treatment of methicillin resistant Staphylococcus aureus (MRSA) and methicillin resistant Coagulase negative Staphylococci (MRCoNS) infections. It is emerging concern about an increase minimum inhibitor concentration (MIC) of vacomycin among S. aureus strains. In this study, we aimed to analyse the trends in MICs of vancomycin, teicoplanin and linezolid over 4 years (2008-2011) period.
dc.language.isoeng
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectTIP, GENEL & İÇECEK
dc.titleGLYCOPEPTIDES AND LINEZOLID MIC CHANGES IN STAPHYLOCOCCUS AUREUS AND COAGULASE NEGATIVE STAPHYLOCOCCI ISOLATES FROM 2008-2011
dc.typeMakale
dc.relation.journalACTA MEDICA MEDITERRANEA
dc.contributor.departmentOndokuz Mayıs Üniversitesi , ,
dc.identifier.volume30
dc.identifier.issue5
dc.identifier.startpage993
dc.identifier.endpage996
dc.contributor.firstauthorID93419


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster